HLI Introduces a Whole Exome Sequencing Product for $250 USD
Human Longevity, Inc. - September 22, 2015
Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, and Discovery Ltd, a pioneering insurer dedicated to making people healthier, announced today that the two companies have entered into a multi-year agreement to offer whole exome, whole genome and cancer genome sequencing to Discovery’s clients in South Africa and the United Kingdom.
No comments:
Post a Comment